54. Br J Cancer. 2018 Mar 20;118(6):e14. doi: 10.1038/bjc.2018.4. Epub 2018 Feb 20.Pathological complete response and prognosis after neoadjuvant chemotherapy forHER2-positive breast cancers before and after trastuzumab era: results from areal-life cohort.Hamy AS, Belin L, Bonsang-Kitzis H, Paquet C, Pierga JY, Lerebours F, Cottu P,Rouzier R, Savignoni A, Lae M, Reyal F.Erratum for    Br J Cancer. 2016 Jan 12;114(1):44-52.This corrects the article DOI: 10.1038/bjc.2017.85.DOI: 10.1038/bjc.2018.4 PMCID: PMC5908674PMID: 29462131 